BioBridgeXAll companies

Black Diamond Therapeutics, Inc.

Biotechnology company · Cambridge, Massachusetts, United States · Nasdaq: BDTX

Black Diamond Therapeutics, Inc. is a biotechnology company headquartered in Cambridge, Massachusetts, United States. Its earliest recorded incorporation is in 2016. Its shares trade on Nasdaq under the ticker BDTX. It has reported private securities offerings to the US SEC, most recently $85 million sold in a notice filed in 2019.

Profile compiled from public records. Is this your company? Request a correction or update

Black Diamond Therapeutics at a glance

Typebiotechnology company
HeadquartersCambridge, Massachusetts, United States
Earliest incorporation on record2016
Stock listingNasdaq: BDTX
SEC industryBiological Products, (No Diagnostic Substances)
SEC CIK1701541

What does Black Diamond Therapeutics do?

Private fundraising reported to the SEC

6 Form D notices; the most recent reported $85 million sold (2019).

Frequently asked questions about Black Diamond Therapeutics

Where is Black Diamond Therapeutics headquartered?

Black Diamond Therapeutics, Inc. is headquartered in Cambridge, Massachusetts, United States.

What does Black Diamond Therapeutics do?

Black Diamond Therapeutics, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).

Is Black Diamond Therapeutics a public company?

Yes. Black Diamond Therapeutics, Inc. trades on Nasdaq under the ticker BDTX.

When was Black Diamond Therapeutics founded?

The earliest incorporation on record for Black Diamond Therapeutics, Inc. is in 2016, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.